Author:
Fenoglio Roberta,Fervenza Fernando,Roccatello Dario
Publisher
Springer International Publishing
Reference91 articles.
1. Jordan N, Lutalo PMK, D’Cruz D (2013) Novel therapeutic agents in clinical development for systemic lupus erythematosus. BMC J 11:120–130
2. Gottenberg J-E, Lorenzo N, Sordet C, Theulin A, Chatelus E, Sibilia J (2014) When biologics should be used in systemic lupus erythematosus? Presse Med 43:e181–e185
3. Ginzler EM, Moldovan I (2004) Systemic lupus erythematosus trials: successes and issues. Curr Opin Rheumatol 16:499–504
4. Andreoli L, Reggia R, Pea L, Frassi M, Zanola A, Cartella S, Franceschini F, Tincani A (2014) Belimumab for the treatment of refractory systemic lupus erythematosus: real-life experience in the first year of use in 18 Italian patients. IMAJ 16:651–653
5. Zonana-Nacach A, Barr SG, Magder LS, Petri M (2000) Damage in systemic lupus erythematosus and its association with corticosteroids. Arthritis Rheum 43:1801–1808